Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEAT: OFS with Anastrozole vs Exemestane in Chinese Premenopausal Breast Cancer
NCT02440230Phase 2Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- May 2015
- Primary completion
- Dec 2021
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of anastrozole in breast cancer, sponsored by Shanghai Jiao Tong University School of Medicine. Started May 2015; status: completed.
02
Drugs
anastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02440230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02440230.